The October issue of the Drug Safety Update from the MHRA discusses a recent meta-analysis that has raised concerns about a possible modest increase in the risk of some cardiovascular events in postmenopausal women who use calcium and vitamin D supplements to prevent osteoporotic fractures. The MHRA notes that there are limitations to the data and reiterates that no change to prescribing practice is currently recommended.